PMID- 34274313 OWN - NLM STAT- MEDLINE DCOM- 20211228 LR - 20230708 IS - 1097-6744 (Electronic) IS - 0002-8703 (Print) IS - 0002-8703 (Linking) VI - 242 DP - 2021 Dec TI - Association of STEMI regionalization of care with de facto NSTEMI regionalization. PG - 1-5 LID - S0002-8703(21)00181-2 [pii] LID - 10.1016/j.ahj.2021.07.002 [doi] AB - The regionalization of care for ST elevation myocardial infarction (STEMI) may unintentionally concentrate patients with non-ST elevation myocardial infarction (NSTEMI) into percutaneous coronary intervention (PCI) capable hospitals. This could lead to benefits such as increased access to PCI-capable hospitals, but could cause harms such as crowding in some hospitals with decreased patient volume and revenue in others. We set out to assess whether STEMI regionalization programs concentrated patients with NSTEMI at STEMI-receiving hospitals. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Montoy, Juan Carlos C AU - Montoy JCC AD - Department of Emergency Medicine, University of California, San Francisco. Electronic address: juancarlos.montoy@ucsf.edu. FAU - Shen, Yu-Chu AU - Shen YC AD - Naval Postgraduate School. FAU - Krumholz, Harlan M AU - Krumholz HM AD - Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine; Department of Health Policy and Management, Yale School of Public Health; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital. FAU - Hsia, Renee Y AU - Hsia RY AD - Department of Emergency Medicine, University of California, San Francisco; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco. LA - eng GR - R01 HL114822/HL/NHLBI NIH HHS/United States GR - R01 HL134182/HL/NHLBI NIH HHS/United States GR - UL1 TR001863/TR/NCATS NIH HHS/United States PT - Letter PT - Research Support, N.I.H., Extramural DEP - 20210715 PL - United States TA - Am Heart J JT - American heart journal JID - 0370465 SB - IM MH - *Hospital Planning/organization & administration MH - Humans MH - *Non-ST Elevated Myocardial Infarction/therapy MH - Percutaneous Coronary Intervention MH - *ST Elevation Myocardial Infarction/therapy PMC - PMC8568654 MID - NIHMS1734981 COIS- Conflicts of interest In the past three years, Harlan Krumholz received expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing. He is an owner of Refactor Health and HugoHealth, and had grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, the U.S. Food and Drug Administration, Johnson & Johnson, and the Shenzhen Center for Health Information. EDAT- 2021/07/19 06:00 MHDA- 2021/12/29 06:00 PMCR- 2022/12/01 CRDT- 2021/07/18 20:33 PHST- 2020/11/23 00:00 [received] PHST- 2021/07/07 00:00 [accepted] PHST- 2021/07/19 06:00 [pubmed] PHST- 2021/12/29 06:00 [medline] PHST- 2021/07/18 20:33 [entrez] PHST- 2022/12/01 00:00 [pmc-release] AID - S0002-8703(21)00181-2 [pii] AID - 10.1016/j.ahj.2021.07.002 [doi] PST - ppublish SO - Am Heart J. 2021 Dec;242:1-5. doi: 10.1016/j.ahj.2021.07.002. Epub 2021 Jul 15.